Episode 308: Neal and Toby dive into Tesla’s Q1 earnings report which certainly had its ups and downs with the announcement of a new affordable model despite having an abysmal sales performance. Then, the FTC just banned noncompete agreements because it believes it could raise the earnings of Americans. Next, Meta just released its chat bot and wants to make sure everyone knows about it. Meanwhile, there could be a new miracle drug that is a fraction of the cost of Ozempic. Also, a Finnish company wants to solve the world’s coffee supply problem with AI. Lastly, Armand Duplantis breaks his own pole vaulting record and there’s a cash incentive why. 00:00 - Intro 2:45 - Tesla’s optimistic future 7:00 - FTC bans noncompete agreements 10:30 - Meta AI is here 13:45 - Newest miracle drug for cheap? 18:00 - Cup of AI joe 21:00 - Pole vault your incentives Get your Morning Brew Daily Merch HERE: https://shop.morningbrew.com/products/morning-brew-daily-sweatshirt?utm_medium=multimedia&utm_source=podcast&utm_campaign=mbd&utm_content=shownotes Listen to Morning Brew Daily Here: https://link.chtbl.com/MBD Watch Morning Brew Daily Here: https://www.youtube.com/@MorningBrewDailyShow

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.